Sycale Advisors’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-714,404
| Closed | -$3.43M | – | 24 |
|
|
2020
Q4 | $3.43M | Buy |
714,404
+142,700
| +25% | +$685K | 2.44% | 13 |
|
|
2020
Q3 | $2.29M | Buy |
571,704
+211,958
| +59% | +$850K | 1.97% | 13 |
|
|
2020
Q2 | $1.65M | Buy |
359,746
+44,721
| +14% | +$205K | 1.26% | 13 |
|
|
2020
Q1 | $1.03M | Hold |
315,025
| – | – | 0.76% | 14 |
|
|
2019
Q4 | $1.36M | Buy |
+315,025
| New | +$1.36M | 1.08% | 13 |
|